Orthobiologics

AlloSource enrolled the first patient in a study to evaluate the effectiveness of ProChondrix CR® fresh cryopreserved osteochondral allograft, when used on...

Atreon Orthopedics received FDA 510(k) clearance to market the Rotium Bioresorbable Wick for the treatment of rotator cuff injuries....

BONESUPPORT launched BONIFY demineralized bone matrix in the U.S....

Fidia introduced NuDYN acellular amnion-derived injectable allograft, the first product in the company's new U.S. orthobiologic portfolio....

AlloSource revealed that ProChondrix® CR fresh cryopreserved osteochondral allograft now has a two-year shelf life, based on the results of real-time testing....

MTF Biologics and ConMed launched CartiMax® Viable Cartilage Allograft, an off-the-shelf putty-like cartilage for use in the knee, foot and ankle....

CartiHeal announced treatment of the 150th patient in the IDE clinical study of Agili-C for knee cartilage repair....

Cerapedics' i-FACTOR Peptide Enhanced Bone Graft is featured in an issued ISASS bone grafting policy with recommendations on use and...

Aesculap Biologics achieved 50% enrollment in its Phase III clinical trial of NOVOCART® 3D, an autologous chondrocyte transplantation system to treat articular...

Medtronic launched Grafton Demineralized Bone Matrix in Japan for spine and orthopedic procedures. ...